Supplementary Material-SM1 from Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity
Kirsi Ketola(University of Eastern Finland), G. Steven Bova(Tampere University)
Cited by 0
Related Papers
Fanconi anemia pathway regulation by FANCI in prostate cancer
|Frontiers in Oncology|2023|5
Monensin Induced Oxidative Stress Reduces Prostate Cancer Cell Migration and Cancer Stem Cell Population
|InTech eBooks|2012|4
DPYSL3B is a regulator of chemoresistance via DNA repair and metabolic reprogramming in prostate cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1